All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| TRVI / Trevi Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RNA / Avidity Biosciences, Inc.
|
|
|
|
|
|
|
|
| APLT / Applied Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SPSB / SPDR Series Trust - SPDR Portfolio Short Term Corporate Bond ETF
|
|
|
|
|
|
|
|
| BSV / Vanguard Bond Index Funds - Vanguard Short-Term Bond ETF
|
|
|
|
|
|
|
|
| IBDP / iShares Trust - iShares iBonds Dec 2024 Term Corporate ETF
|
|
|
|
|
|
|
|
| PAGP / Plains GP Holdings, L.P. - Limited Partnership
|
|
|
|
|
|
|
|
| SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| MDGL / Madrigal Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| PHAT / Phathom Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| MIRM / Mirum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| MBB / iShares Trust - iShares MBS ETF
|
|
|
|
|
|
|
|
| EIGRQ / Eiger BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| TSAT / Telesat Corporation
|
|
|
|
|
|
|
|
| CYBN / Cybin Inc.
|
|
|
|
|
|
|
|
| DAWN / Day One Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| US169CVR0169 / CONTRA CHINOOK THERAPE
|
|
|
|
|
|
|
|
| FIDELITY INV MMTRSY 1 680
/ COMM (X9USDFIDT) |
|
|
|
|
|
|
|
| LQD / iShares Trust - iShares iBoxx $ Investment Grade Corporate Bond ETF
|
|
|
|
|
|
|
|
| FULC / Fulcrum Therapeutics, Inc.
|
|
|
|
|
|
|
|
| XFOR / X4 Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| STRO / Sutro Biopharma, Inc.
|
|
|
|
|
|
|
|
| ATHA / Athira Pharma, Inc.
|
|
|
|
|
|
|
|
| MRNS / Marinus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| TCRX / TScan Therapeutics, Inc.
|
|
|
|
|
|
|
|
| KYMR / Kymera Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ARDX / Ardelyx, Inc.
|
|
|
|
|
|
|
|
| HIGH / Simplify Exchange Traded Funds - Simplify Enhanced Income ETF
|
|
|
|
|
|
|
|
| AGIO / Agios Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CRNX / Crinetics Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| FLRN / SPDR Series Trust - SPDR Bloomberg Investment Grade Floating Rate ETF
|
|
|
|
|
|
|
|
| SLQD / iShares Trust - iShares 0-5 Year Investment Grade Corporate Bond ETF
|
|
|
|
|
|
|
|
| KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
| HRTX / Heron Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AKRO / Akero Therapeutics, Inc.
|
|
|
|
|
|
|
|
| KYN / Kayne Anderson Energy Infrastructure Fund, Inc.
|
|
|
|
|
|
|
|
| ACHV / Achieve Life Sciences, Inc.
|
|
|
|
|
|
|
|
